{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:09:08Z","timestamp":1789751348536,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jfo.2026.104926","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:08:25Z","timestamp":1781298505000},"page":"104926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Caract\u00e9ristiques d\u00e9mographiques, cliniques et th\u00e9rapeutiques d\u2019une cohorte d\u2019orbitopathie dysthyro\u00efdienne Fran\u00e7aise"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-1981","authenticated-orcid":false,"given":"A.","family":"Lavigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lecolier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dupre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3321-9014","authenticated-orcid":false,"given":"S.","family":"Bresch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-7126","authenticated-orcid":false,"given":"A.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2026.104926_bib0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.revmed.2022.01.006","article-title":"L\u2019orbitopathie basedowienne\u00a0: diagnostic, \u00e9pid\u00e9miologie et principes de traitement","volume":"43","author":"Lun","year":"2022","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfo.2026.104926_bib0155","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4103\/ijo.IJO_104_20","article-title":"Clinical profile of thyroid eye disease and factors predictive of disease severity","volume":"68","author":"Muralidhar","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/IOP.0000000000001942","article-title":"The \u201cQuiet TED\u201d\u00a0\u2013\u00a0A special subgroup of thyroid eye disease","volume":"37","author":"I\u00f1iguez-Ariza","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2026.104926_bib0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/joco.joco_223_21","article-title":"Epidemiological status of thyroid eye disease in central Iran","volume":"34","author":"Eshraghi","year":"2022","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/meajo.MEAJO_91_17","article-title":"Epidemiology and clinical features of thyroid-associated orbitopathy in Accra","volume":"24","author":"Ackuaku-Dogbe","year":"2017","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jfo.2013.07.004","article-title":"Prise en charge diagnostique et th\u00e9rapeutique d\u2019une orbitopathie dysthyro\u00efdienne\u00a0: une affection multidisciplinaire","volume":"36","author":"Leray","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.beem.2011.09.004","article-title":"Prevention of Graves\u2019 ophthalmopathy","volume":"26","author":"Bartalena","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2026.104926_bib0185","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.jfo.2026.104926_bib0190","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bjophthalmol-2014-305649","article-title":"Thyroid eye disease: a Southeast Asian experience","volume":"99","author":"Lim","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0195","doi-asserted-by":"crossref","first-page":"e0176064","DOI":"10.1371\/journal.pone.0176064","article-title":"Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jfo.2026.104926_bib0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9394(14)70439-8","article-title":"Chronology of Graves\u2019 ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0205","first-page":"178","article-title":"Prevalence and severity of ocular involvement in Graves\u2019 disease according to sex and age: a clinical study from Babol, Iran","volume":"9","author":"Gharib","year":"2018","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.jfo.2026.104926_bib0210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/mus.27118","article-title":"Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease","volume":"63","author":"Claytor","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jfo.2026.104926_bib0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-0404.2012.01693.x","article-title":"Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan","volume":"127","author":"Chen","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jfo.2026.104926_bib0220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/thy.2000.10.799","article-title":"Increased frequency of euthyroid ophthalmopathy in patients with Graves\u2019 disease associated with myasthenia gravis","volume":"10","author":"Marin\u00f2","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.jfo.2026.104926_bib0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11940-011-0151-8","article-title":"Treatment of ocular myasthenia gravis","volume":"14","author":"Haines","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jfo.2026.104926_bib0230","first-page":"438","article-title":"Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases","volume":"82","author":"Marin\u00f2","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfo.2026.104926_bib0235","doi-asserted-by":"crossref","first-page":"e209282","DOI":"10.1212\/WNL.0000000000209282","article-title":"Pearls & oysters: thyroid-associated ophthalmopathy and transient neuromuscular junction disorder due to Graves disease","volume":"102","author":"Zouvelou","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2026.104926_bib0240","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bjo.77.12.822","article-title":"Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy","volume":"77","author":"Vargas","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/IIO.0000000000000277","article-title":"Thyroid eye disease and myasthenia gravis","volume":"59","author":"Bojikian","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jfo.2026.104926_bib0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JND-190407","article-title":"Ocular weakness in myasthenia gravis: changes in affected muscles are a distinct clinical feature","volume":"6","author":"De Meel","year":"2019","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.jfo.2026.104926_bib0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fendo.2018.00801","article-title":"Rare co-occurrence of ocular myasthenia gravis and thyroid-associated orbitopathy (Ophthalmopathy) in an individual with hypothyroidism","volume":"9","author":"An","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfo.2026.104926_bib0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2 years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jfo.2026.104926_bib0265","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1007\/s10072-024-07728-w","article-title":"Clinical characteristics and therapeutic effect of myasthenia gravis coexisting with thyroid eye disease","volume":"45","author":"Chen","year":"2024","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jfo.2026.104926_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220153","article-title":"Hickam's dictum: myasthenia gravis presenting concurrently with Graves\u2019 disease","volume":"2017","author":"Sehgal","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jfo.2026.104926_bib0275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfo.2026.104926_bib0280","doi-asserted-by":"crossref","first-page":"104301","DOI":"10.1016\/j.jfo.2024.104301","article-title":"\u00c9tat des lieux de la prise en charge de l\u2019orbitopathie dysthyroid\u00efenne mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re active en France \u00e0 partir de 28 centres experts m\u00e9tropolitains","volume":"48","author":"Ben Miloud","year":"2025","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2026.104926_bib0285","doi-asserted-by":"crossref","first-page":"1160172","DOI":"10.3389\/fendo.2023.1160172","article-title":"Influence of biological sex, age and smoking on Graves\u2019 orbitopathy\u00a0\u2013\u00a0a ten-year tertiary referral center analysis","volume":"14","author":"Oeverhaus","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.jfo.2026.104926_bib0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/bjo-2024-325346","article-title":"Low clinical activity score, \u2018progressive\u2019 thyroid eye disease: presentations of 1439 patients from a tertiary centre in Hong Kong","volume":"109","author":"Lai","year":"2025","journal-title":"Br J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122600152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155122600152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:27:54Z","timestamp":1789748874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155122600152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S018155122600152X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2026.104926","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caract\u00e9ristiques d\u00e9mographiques, cliniques et th\u00e9rapeutiques d\u2019une cohorte d\u2019orbitopathie dysthyro\u00efdienne Fran\u00e7aise","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2026.104926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104926"}}